Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) saw unusually-high trading volume on Friday . Approximately 6,523 shares traded hands during trading, an increase of 127% from the previous session's volume of 2,871 shares.The stock last traded at $10.57 and had previously closed at $10.41.
Bavarian Nordic Price Performance
The firm has a 50-day moving average of $9.94 and a 200-day moving average of $10.37. The stock has a market cap of $2.48 billion, a PE ratio of 11.88 and a beta of 1.27.
Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) last released its earnings results on Thursday, March 12th. The company reported ($0.20) earnings per share (EPS) for the quarter. Bavarian Nordic had a return on equity of 11.27% and a net margin of 22.20%.The business had revenue of $226.16 million for the quarter. Equities analysts forecast that Bavarian Nordic will post 0.67 EPS for the current fiscal year.
About Bavarian Nordic
(
Get Free Report)
Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic's operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.
The company's commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bavarian Nordic, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic wasn't on the list.
While Bavarian Nordic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
